Intra-tumoral and peripheral PD-1/PD-L1 expression correlation in head and neck cancer
Laryngo-Rhino-Otologie · 01.05.2024 · 103 (S 02 S 02) · S228
DOI: 10.1055/s-0044-1784747 ↗Kurz gefasst
Fachartikel in der Zeitschrift Laryngo-Rhino-Otologie, erschienen am 01.05.2024. Verfasst von Christian Idel und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Background Head and neck squamous cell carcinoma (HNSCC) represents a heterogeneous group of malignant disease of the oral cavity, pharynx and larynx. HNSCC cells evade the immune system through alterations in their immunogenicity, production of immunosuppressive mediators, and induction of immunomodulatory cell types. The immune status of solid HNSCC can be considered as hot, cold or excluded based on the distribution of tumor infiltrating immune cells. In this context immunotherapies via blockade of checkpoint molecules programmed cell death 1 (PD-1) and programmed cell death ligand 1 (PD-L1) have significantly improved therapeutic outcomes in different cancer types. In HNSCC, intra-tumoral expression levels of PD-L1 are used for decision making in checkpoint inhibitor treatment. The significance of PD-L1 as a prognostic indicator is still controversial because both PD-1 and PD-L1 are also expressed in different types of circulating immune cells and the interaction of systemic and intra-tumoral cell-type-specific expression patterns of checkpoint molecules PD-1/PD-L1 has not yet been fully understood. Materials and Methods Using immunohistochemical (IHC) staining and flow cytometry, we correlated the expression patterns of the checkpoint molecules PD1/PD-L1 in peripheral blood CD14/CD16 monocytes and CD4/CD8 T cells with intra-tumoral conditions in patients with head and neck cancer. Results/Conclusion Our data demonstrate significant connections between systemic and intra-tumoral PD-1/PD-L1 immune patterns, both of which may serve as promising combined biomarkers for treatment decisions in patients with head and neck cancer. Publication History Article published online: 19 April 2024 © 2024. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
Zitieren
APA
Idel, C., Ribbat-Idel, J., Bernuth, A. V., Kirfel, J., Pries, R., & Bruchhage, K. (2024). Intra-tumoral and peripheral PD-1/PD-L1 expression correlation in head and neck cancer. Laryngo-Rhino-Otologie, 103(S 02 S 02), S228. https://doi.org/10.1055/s-0044-1784747
Vancouver
Idel C, Ribbat-Idel J, Bernuth AV, Kirfel J, Pries R, Bruchhage K. Intra-tumoral and peripheral PD-1/PD-L1 expression correlation in head and neck cancer. Laryngo-Rhino-Otologie. 2024;103(S 02 S 02):S228. doi:10.1055/s-0044-1784747
BibTeX
@article{Idel2024,
author = {Idel, Christian and Ribbat-Idel, Julika and Bernuth, Amelie von and Kirfel, Jutta and Pries, Ralph and Bruchhage, Karl-Ludwig},
title = {Intra-tumoral and peripheral PD-1/PD-L1 expression correlation in head and neck cancer},
journal = {Laryngo-Rhino-Otologie},
year = {2024},
volume = {103},
number = {S 02 S 02},
pages = {S228},
doi = {10.1055/s-0044-1784747}
}
EUVIMED